Variant report
Variant | esv3315086 |
---|---|
Chromosome Location | chr10:53869479-53870068 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576038223 | chr10:53869492-53869493 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs544883189 | chr10:53869499-53869500 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs561273018 | chr10:53869504-53869505 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs530078619 | chr10:53869507-53869508 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs546965136 | chr10:53869510-53869511 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs560430105 | chr10:53869523-53869524 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs553302993 | chr10:53869547-53869548 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs375740941 | chr10:53869570-53869571 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs532616908 | chr10:53869577-53869578 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190854682 | chr10:53869596-53869597 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs116896704 | chr10:53869605-53869606 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536971795 | chr10:53869620-53869621 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs76271256 | chr10:53869665-53869666 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs116280589 | chr10:53869702-53869703 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs17562140 | chr10:53869707-53869708 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs138293244 | chr10:53869708-53869709 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs180726416 | chr10:53869736-53869737 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs538708540 | chr10:53869739-53869740 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187353365 | chr10:53869743-53869744 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs575733634 | chr10:53869770-53869771 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs34389565 | chr10:53869771-53869772 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs561610026 | chr10:53869774-53869775 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs557969801 | chr10:53869818-53869819 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs142963984 | chr10:53869828-53869829 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs578110781 | chr10:53869831-53869832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs540298518 | chr10:53869863-53869864 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs560524173 | chr10:53869871-53869872 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs540738797 | chr10:53869878-53869879 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs532514571 | chr10:53869880-53869881 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs78699098 | chr10:53869891-53869892 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs564739493 | chr10:53869964-53869965 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs530578407 | chr10:53870024-53870025 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs550350165 | chr10:53870035-53870036 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs139025944 | chr10:53870040-53870041 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs567269108 | chr10:53870043-53870044 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs190947069 | chr10:53870047-53870048 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Dysmorphic features | 21948486 | CNVD |
Epilepsy | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:53865800-53869600 | Weak transcription | Aorta | Aorta |
2 | chr10:53866000-53870200 | Enhancers | Skeletal Muscle Female | skeletal muscle |
3 | chr10:53867000-53869600 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
4 | chr10:53867000-53872400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
5 | chr10:53867200-53869600 | Weak transcription | Psoas Muscle | Psoas |
6 | chr10:53869600-53869800 | Enhancers | Skeletal Muscle Male | skeletal muscle |
7 | chr10:53869600-53870000 | Enhancers | Psoas Muscle | Psoas |
8 | chr10:53869800-53870200 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
9 | chr10:53870000-53875200 | Weak transcription | Psoas Muscle | Psoas |